- Revue Thématique de la Littérature Internationale
- Published:
Testicule non descendu: le point sur les causes et les traitements
Maldescended Testis: causes and treatments
Andrologie volume 10, pages 432–442 (2000)
Références
AMERICAN ACADEMY OF PEDIATRICS: Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. Pediatrics, 1996, 97: 590–594.
AKRE O., LIPWORTH L., CNATTINGIUS S., SPAREN P., EKBOM A. Risk factor patterns for cryptorchidsm and hypospadias. Epidemiology, 1999, 10: 364–369.
BARTHOLD J.S., KRYGER J.V., DERUSHA A.M., DUEL B.P., JEDNAK R., SKAFAR D.F.: Effects of an environmental endocrine disruptor on fetal development, estrogen receptor alpha and epidermal growth factor receptor expression in the procine, male genital tract. J. Urol., 1999, 162: 864–871.
BELLINGER M.F., ABROMOWITZ H., BRANTLEY S.et al.: Orchidopexy: An experimental study of the effect of surgical technique on testicular histology. J. Urol., 1989, 142: 553–555
BENSON G.V., LIM H., PARIA B.C., SATOKATA I., DEY S.K., MAAS R.L.: Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Dev., 1996, 122: 2687–2696.
BERGH A., ROOTH P., WIDMARK A., DAMBER J.E.: Treatment of rats with hCG induces inflammation-like changes in testicular microcirculation. J. Reprod. Fertil., 1987, 79: 135–143.
BICA D.T.G., HADZISELIMOVIC F.: Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study. J. Urol., 1992, 148: 617–620.
CHRISTIANSEN P., MULLER J., BUHL S.et al.: Hormonal treatment of cryptorchidism-hCG or GnRH-a multicentre study. Acta Pediatr., 1992, 81: 605–608.
CORTES D.: Cryptorchidism: Aspects of pathogenesis, histology and treatment. PhD Thesis, Copenhagen, 1998, 1–54.
CORTES D., THORUP J.M., BECK B.L.: Quantitative histology of germ cells in the undescended testes of human fetuses, neonates and infants. J. Urol., 1995, 154: 1188–1192.
CORTES D., THORUP J.M., LINDENBERG S.: Fertility potential after unilateral orchiopexy: simultaneous testicular biopsy and orchiopexy in a cohort of 87 patients. J. Urol., 1996, 155: 1061–1063.
CORTES D. THORUP J.M., VISFELDT J.: Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism. J. Urol., 2000, 163: 1290–1292.
COUGHLIN M.T., BELLINGER M.F., LAPORTE R.E., LEE P.A.: Testicular suture: a significant risk factor for infertility among formerly cryptorchid men. J. Pediatr. Surg., 1998, 33: 1790–1793.
COUGHLIN M.T., BELLINGER M.F., LEE P.A.: Age at unilateral orchiopexy: effect on hormone levels and sperm count in adulthood. J. Urol., 1999, 162: 986–989.
CZEIZEL A.E., HEGEDÜS S., TIMAR L.: Congenital agnormalities and indicators of germinal mutations in the vicinity of an acrylonitrile producing factory. Mut. Res., 1999, 427: 105–123.
DEMIRBILEK S., ATAYURT, H.F., CELIK, N., AYDIN G.: Does treatment with human chorionic gonadotropin induce reversible changes in undescended testes in boys? Pediatr. Surg. Int., 1997, 12: 591–594.
DOCIMO S.G.: The results of surgical therapy for cryptorchidism: a literature review and analysis. J. Urol., 1995, 154: 1148–1152.
DUNKEL L., TASKINEN S., HOVATA O., TILLY J.L., WIKSTRÖM S.: Germ cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult. J. Clin. Invest., 1997, 100: 2341–2346.
EMMEN J.M.A., MCLUSKEY A., ADHAM I.M.et al.: Involvement of Insulin-Like Factor 3 (Insl3) in Diethylstilbestrol-induced cryptorchidism. Endocrinology, 2000, 141: 846–849.
FAGERLI J., SCHNECK F.X., LEE P.A., BELLINGER M.F., WITCHEL S.: Absence of microdeletions in the Y chromosome in patients with a history of cryptorchidism and azoospermia or oligospermia. Fertil. Steril., 1999, 71: 697–700.
FARRER J.H., WALKER A.H., RAJFER J.: Management of the postpubertal cryptorchid testis: a statistical review. J. Urol., 1985, 134: 1071–1076.
FORESTA C., MORO E., GAROLLA A., ONISTO M., FERLIN A.: Y chromosome microdeletion in cryptorchidism and idiopathic infertility. J. Clin. Endocrinol. Metab., 1999, 84: 3660–3665.
GARCIA-RODRIGUEZ J., GARCIA-MARTIN M., NOGUERAS-OANA M.et al.: Exposure to pesticides and cryptorchidism: geographical evidence of a possible association. Environ. Health Perspect., 1996, 104: 1090–1095.
GIWERCMAN A., HANSEN L.L. SKAKKEBAEK N.E.: Initiation of sperm production after bilateral orchiopexy: clinical and biological implications. J. Urol., 2000, 163: 1255–1256.
GRACIA J., GONZALEZ N., GOMEZ M.E., PLAZA L., SANCHEZ J., ALBA J.: Clinical, and anatomical study of 2000 cryptorchid testes. J. Urol., 1995, 75: 697–701.
GRACIA J., SANCHEZ ZALABARDO J., SANCHEZ GARCIA J., GARCIA C., FERRANDEZ A.: Clinical, physical, sperm and hormonal data in 251 adults operated on for cryptorchidism in childhood. B. J. U. Int., 2000, 85: 1100–1103.
HADZISELIMOVIC f., HERZOG B., BUSER M.: Development of cryptorchid testes. Eur. J. Pediatr., 1987, 146 (Suppl 2): S8-S12.
HEISKANEN P., BILLIG H., TOPPARI J.et al.: Apoptotic cell death in the normal and cryptorchid human testis: the effect of human chorionic gonadotropin on testicular cell survival. Pediatr. Res., 1996, 40: 351–356.
HEATON N.D., DAVENPORT M., PRYOR J.P.: Fertility after correction of bilateral undescended testes at the age of 23 years. Brit. J. Urol., 1993, 71: 490–491.
HJERTKVIST M., BERGH A., DAMBER J.-E.: HCG treatment increases intratesticular pressure in the abdominal testis of unilaterally cryptorchid rats. J. Androl., 1988, 9: 116–120.
HJERTKVIST M., LÄCKGREN G., PLOËN L.et al.: Does hCG treatment induce inflammation-like changes in undescended testes in boys? J. Pediatr. Surg., 1993, 28: 254–257.
HOSIE S., WESSEL L., WAAG K.L.: Could testicular descent in humans be promoted by direct androgen stimulation of the gubernaculum testis? Eur. J. Pediatr. Surg., 1999, 9: 37–41.
HUFF D.S., HADZISELIMOVIC F., SNYDER H.M., DUCKETT J.W., KEATING M.A.: Postnatal testicular maldevelopment in unilateral cryptorchidism. J. Urol., 1989, 142: 546–548.
HUTSON J.M., HASTHORPE S., HEYNS C.: Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr. Rev., 1997, 18: 259–280.
JOHANSEN T.E.B., KLEIN H.: Evidence of androgen receptivity in the pathway of testicular descent in humans. Eur. Urol., 1993, 23: 466–468.
JONES M.E., SWERDLOW A.J., GRIFFTH M., GOLDACRE M.J.: Prenatal risk factors for cryptorchidism: a record linkage study. Paed. Perin. Epid., 1998, 12: 383–396.
KALEVA M., ARSALO A., LOUHIMO I.et al.: Treatment with human chorionic gonadotrophin for cryptorchidism: clinical and histological effects. Int. J. Androl., 1996, 19: 293–298.
KERR J.B., SHARPE R.M.: Focal disruption of spermatogenesis in the testis of adult rats after a single administration of human chorionic gonadotrophin. Cell Tissue Res., 1989, 257: 163–169.
KOLON T.F., WIENER J.S., LEWITTON M., ROTH R.D., GONZALES E.D., LAMB D.J.: Analysis of homeobox gene HOXA10 mutations in cryptorchidism. J. Urol., 1999, 161: 275–280.
KRAUSZ C., QUINTANA-MURCI L., FELLOUS M., SIFFROI J.P., MCELREAVEY K.: Absence of mutations involving the INSL3 gene in human idiopathic cryptorchidism. Mol. Hum. Reprod., 2000, 6: 298–302.
LALA R., MATARAZZO P., CHIABOTTO P.et al.: Early hormonal and surgical treatment of cryptorchidism. J. Urol., 1997, 157: 1898–1901.
LENZI A., GANDINI L., LOMBARDO F.et al.: Unilateral cryptorchidism corrected in prepubertal age: evaluation of sperm parameters, hormones, and sperm antibodies in adult age. Fertil. Steril., 1997, 67: 943–948.
MADDOCK W.O., NELSON W.O.: The effects of chorionic gonadotrophin in adult men: increase estrogen and 17-ketosteroid excretion, gynecomastia, Leydig cell stimulation and seminiferous tubule damage. J. Clin. Endocrinol. Metab., 1952, 12: 985–1007.
MANDAT K.M., WIECZORKIEWICZ B., GUBATAKACATA M., SYPNIEWSKI J., BUJOK G.: Semen analysis of patients who had orchidopexy in childhood. Eur. J. Pediatr. Surg., 1994, 4: 94–97.
MANGEL W., HEINZ H.A., SIPPEL W.G., HECKER W.C.: Studies on cryptorchidism: a comparison of histological findings in the germinative epithelium before and after the second year of life. J. Pediatr. Surg., 1974, 9: 445–450.
MARTIN D.C., MENCK H.R.: The undescended testis: management after puberty. J. Urol., 1975, 114: 77–85.
MASI G., MILLEPIEDI S., BROVEDANI P., FAVILLA L., MUCCI M.: Psychopathological aspects of cryptorchidism in children and adolescents. Ch. Psych. Hum. Dev., 1999, 30: 75–85.
McALEER I.M., PACKER M.G., KAPLAN G.W., SCHERZ H.C., KROUS H.F., BILLMAN G.F.: Fertility index analysis in cryptorchidism. J. Urol., 1995, 153: 1255–1258.
MININBERG D.T., RODGER J.C., BEDFORD J.M.: Ultrastructural evidence of the onset of testicular pathological conditions in the cryptorchid human testis within the first year of life. J. Urol., 1982, 128: 782–788.
MÖLLER H., SKAKKEBAEK N.E.: Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes and Control, 1997, 8: 904–912.
MOUL J.W., BELMAN A.B.: A review of surgical treatment of undescended testes with emphasis on anatomical position. J. Urol., 1988, 140: 125–128.
MUTOH A., SASAGAWA I., TATENO T., SAWAMURA T., NAKADA T.: Long arm deletion of chromosome 10 in a boy with monorchidism. Scand. J. Urol. Nephrol., 1999, 33: 77–78.
NEF S., PARADA L.F.: Cryptorchidism in mice mutant for Insl3. Nat. Genet., 1999, 22: 295–299.
OKUYAMA A., NONOMURA N., NAKAMURA M.et al.: Surgical management of undescended testis: retrospective study of potential fertility in 274 cases. J. Urol., 1989, 142: 749–751.
PYÖRÄLÄ S., HUTTUNEN N.P., UHARI M.: A review and meta-analysis of hormonal treatment of cryptorchidism. J. Clin. Endocrinol. Metab., 1995, 80: 2795–2799.
RIEBEL T., HERMANN C., WIT J., SELLIN S.: Ultrasonographic late results after surgically treated cryptorchidism. Pediatr. Radiol., 2000, 30: 151–155.
RIJLI F.M., MATYAS R., PELLEGRINI M.et al.: Cryptorchidism and homeotic transformations of spinal nerves and vertebrae in Hoxa-10 mutant mice. Proc. Natl. Acad. Sci. USA, 1995, 92: 8185–8189.
ROGERS E., TEHAN S., GALLAGER H.et al.: The role of orchiectomy in the management of postpubertal cryptorchidism. J. Urol., 1998, 159: 851–854.
SATOKATA I., BENSON G., MAAS R.: Sexually dimorphic sterility phenotypes in Hoxa 10-deficient mice. Nature, 1995, 374: 460–463.
SCHINDLER A.M., DIAZ P., CUENDET A., SIZONENKO P.C.: Cryptorchidism: a morphological study of 670 biopsies. Helv. Paediat. Acta, 1987, 42: 145–158.
SHIN D., LEMACK G.E., GOLDSTEIN M.: Induction of spermatogenesis and pegnancy after adult orchiopexy. J. Urol., 1997, 158: 2242.
SUZUKI Y., SASAGAWA I., NAKADA T., ONMURA Y.: Bilateral cryptorchidism associated with terminal deletion of 10q. Urol. Int., 1998, 61: 186–187.
TASKINEN S., HOVATA O., WIKSTRÖM S.: Early treatment of cryptorchidism, semen quality and testicular endocrinology. J. Urol, 1996, 156: 82–84.
TASKINEN S., HOVATA O., WIKSTRÖM S.: Sexual development in patients treated for cryptorchidism. Scand. J. Urol. Nephrol., 1997, 31: 361–364.
TASKINEN S., WIKSTRÖM S.: Effect of age at operation, location of testis and proliferative hormonal treatment on testicular growth after cryptorchidism. J. Urol., 1997, 158: 471–473.
VAN VLIET J., ROMMERTS F.F.G., DEROOIJ D.G., BUWALDA G., WENSING C.J.G.: Reduction of testicular blood flow and focal degeneration of tissue in the rat after administration of human chorionic gonadotrophin. J. Endocrinol., 1988, 117: 51–57.
WARD J.F., CILENTO B.G., KAPLAN G.W., VELLING T., PUCKETT M., STOCK J.: The ultrasonic description of post pubertal testicles in men who have undergone prepubertal orchiopexy for cryptorchidism. J. Urol., 2000, 163: 1448–1450.
WIDMARK A., BERGH A., DAMBER J.E., SMEDEGARD G.: Leucocytes mediate the hCG-induced increase in testicular venular permeability. Mol. Cell. Endocrinol., 1987, 53: 25–31.
WEIDNER I.S., MÖLLER H., JENSEN K.T., SKAKKEBAEK N.E.: Cryptorchidism and hypospadias in sons of gardners and farmers. Environ. Health Perspect., 1998, 106: 793–796.
WEIDNER I.S., MÖLLER H., JENSEN K.T., SKAKKEBAEK N.E.: Risk factors for cryptorchidism and hypospadias. J. Urol., 1999, 161: 1606–1609.
WIENER J.S., MARCELLI M., GONZALES E.T., ROTH D.R., LAMB D.J.: Androgen receptor gene alterations are not associated with isolated cryptorchidism. J. Urol., 1998, 160: 863–865.
ZIMMERMANN S., STEDING G., EEMMEN J.A.A.et al.: Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol. Endocrinol., 1999, 13: 681–691.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mieusset, R. Testicule non descendu: le point sur les causes et les traitements. Androl. 10, 432–442 (2000). https://doi.org/10.1007/BF03034500
Issue Date:
DOI: https://doi.org/10.1007/BF03034500